LexDanaLexDanabeta
Inventor

Jurg R. Pfister

Inventor
Los Altos, CA, US

Overview

59→
Patents
1976–2019
Patent span
Chemistry
Primary field (CPC C)

Patents· 59 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds40%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
A61KPreparations for medical, dental or toiletry purposes9%
C07CAcyclic or carbocyclic compounds9%
Y02ATechnologies for adaptation to climate change6%
C07HSugars3%
C07JSteroids3%
B21DWorking or processing of sheet metal or metal tubes, rods or profiles without essentially removing material1%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium1%
C11CFatty acids from fats, oils or waxes1%
PatentTitleYear
10,344,012Treprostinil derivative compounds and methods of using same20199,845,305Treprostinil derivative compounds and methods of using same20179,505,737'Treprostinil derivative compounds and methods of using same'20169,371,264'Treprostinil derivative compounds and methods of using same'20169,320,731'7-azoniabicyclo[2.2.1]heptane derivatives, methods of production, and pharmaceutical uses thereof'20168,742,131'7-azoniabicyclo [2.2.1] heptane derivatives, methods of production, and pharmaceutical uses thereof'20148,742,134'7-azoniabicyclo[2.2.1]heptane derivatives, methods of production, and pharmaceutical uses thereof'20148,426,611'7-azoniabicyclo[2.2.1]heptane derivatives, methods of production, and pharmaceutical uses thereof'20138,114,891'4-substituted quinuclidine derivatives, methods of production, pharmaceutical uses thereof'2012RE042412'Materials and methods for the treatment of gastroesophageal reflux disease'20117,501,436'5-HT3 receptor antagonists and methods of use'20097,384,973'Materials and methods for treating hypercholesterolemia'20087,265,142'Materials and methods for the treatment of hypertension and angina'20077,125,886'5-HT3 receptor antagonists and methods of use'20067,091,200'Quinazolone derivatives as alpha 1A/B adrenergic receptor antagonists'20067,022,722'Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis'20066,958,355'Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis'20056,900,220'Quinazolone derivatives as alpha 1A/B adrenergic receptor antagonists'20056,864,279'Materials and methods for treating coagulation disorders'20056,770,655'5-HT3 receptor antagonists and methods of use'20046,768,008'Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis'20046,680,387'Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis'20046,608,097'Materials and methods for the treatment of hypertension and angina'20036,559,153'Quinazoline derivatives as alpha-1 adrenergic antagonists'20036,552,046'Materials and methods for the treatment of gastroesophageal reflux disease'20036,087,365'10,11-methanodibenzosuberane derivatives'20005,998,387'Method for using A.sub.1 adenosine receptor agonists'19995,889,007'10, 11-methanodibenzosuberane derivatives'19995,874,434'10,11-methanodibenzosuberane derivatives'19995,859,014'Pyrimidinedione, pyrimidinetrione, triazinedione and tetrahydroquinazolinedione derivatives as .alpha..sub.1 -adrenergic receptor antagonists'19995,789,416'N.sup.6 mono heterocyclic substituted adenosine derivatives'19985,736,528'N.sup.6 -(epoxynorborn-2-yl) adenosines as A.sub.1 adenosine receptor agonists'19985,688,795'›3-(4-phenylpiperazin-1-yl)propyl-amino, thio and oxy!-pyridine, pyrimidine and benzene derivatives as .alpha..sub.1 -adrenoceptor antagonists'19975,668,139'A1 adenosine receptor agonists and antagonists'19975,654,304'10,11-methanodibenzosuberane derivatives'19975,643,909'10,11-Methanodibenzosuberane derivatives'19975,436,264'N-aryloxyalkyl tryptamine .alpha..sub.1 -adrenergic receptor antagonists'19955,082,847'Carbostyril compounds connected via an oxyalkyl group with a piperidine ring and having pharmaceutical utility'19924,889,866'Arylsulfonyl dihydropyridine derivatives'19894,663,320'(2-oxo-1,2,3,5-tetrahydroimidazo[2,1-b]quinoazolinyl)oxyalkylamides, compositions and the use thereof'19874,598,938'Coupling device for making a permanent pipe connection'19864,548,949'+2-[(3,4-Methylenedioxy)phenethyl]-5-[(3-carboxamido-4-hy droxy)-.alpha.-hydroxybenzyl]pyrrolidines'19854,543,361'.+-.2-[Phenethyl]-5-[(3,4-methylenedioxy)-.alpha.-hydroxybenzyl]py rrolidine antihypertensives and use thereas'19854,515,727'Allene containing arachidonic acid derivatives'19854,353,922'Anticholinergic bronchodilators'19824,250,097'Compositions for and a method of preventing diabetic complications'19814,228,171'Antichlorinergic bronchodilators'19804,217,361'Disubstituted xanthone-2-carboxylic acid antiallergy agents'19804,208,423'Anticholinergic bronchodilators'19803,993,669'Mono- and disubstituted 1.4-benzopyrone-6-carboxylic acids and derivatives thereof'19763,989,721'Disubstituted xanthone carboxylic acid compounds'19763,989,720'Disubstituted xanthone carboxylic acid compounds'19763,988,352'Disubstituted xanthone carboxylic acid compounds'19763,979,414'Disubstituted xanthone carboxylic acid compounds'19763,965,115'Disubstituted xanthone carboxylic acid compounds'19763,963,753'Disubstituted xanthone carboxylic acid compounds'19763,963,752'Disubstituted xanthone carboxylic acid compounds'19763,951,618'Method of use of, and compositions containing, disubstituted xanthone carboxylic acid compounds'19763,949,084'Novel substituted xanthone carboxylic acid compounds'1976

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1976–1999Patents assigned to SYNTEX INC (27)· patent assignee history
1976–2016Based in Los Altos, CA, US· patent location history
1985–2000Based in Palo Alto, CA, US· patent location history
1986Based in Ebmatingen, CH· patent location history
2003–2007Patents assigned to ARYX THERAPEUTICS (8)· patent assignee history
2005–2011Patents assigned to ARYX THERAPEUTICS INC (5)· patent assignee history
2013–2016Patents assigned to THERON PHARMACEUTICALS INC (4)· patent assignee history
2014–2016Based in Sunnyvale, CA, US· patent location history
2016–2019Patents assigned to CORSAIR PHARMA INC (4)· patent assignee history
2017–2019Based in South San Francisco, CA, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
SYNTEX INC271976–1999
ARYX THERAPEUTICS82003–2007
ARYX THERAPEUTICS INC52005–2011
CORSAIR PHARMA INC42016–2019
THERON PHARMACEUTICALS INC42013–2016
Locations
LocationPatentsSpan
Los Altos, California, US511976–2016
Sunnyvale, California, US32014–2016
South San Francisco, California, US22017–2019
Palo Alto, California, US21985–2000
Ebmatingen, CH11986